Pharma Companies List in India

By 2023, the global pharmaceutical market is expected to reach USD 1.5 trillion. In the global pharmaceutical market, India plays a critical role. India meets more than half of the global demand for various vaccinations and 40% of the market for generic goods in the United States.

During the period 2019-23, India’s pharmaceutical spending is predicted to grow at an annual rate of 8-11 percent, reaching 28-32 billion US dollars.

Pharma Companies in India is leading in International Market.

The following are the Top Ten Pharma Companies in India:

Aurobindo Pharma 

Mr PV Ramprasad Reddy and Mr K Nityanda Reddy established the organization in 1986. Aurobindo Pharma was a fantasy of the exceptionally dedicated proficient gathering. The organization began its activities through a little assembling Semi-Synthetic Penicillin (SSP) bunch at Pondicherry in 1988-89. 

Aurobindo Pharma became one of the public organizations in 1992 and got itself recorded in the securities exchange of India in 1995. Other than it is an at-market administrative role in Semi-Synthetic Penicilling, it has likewise its availability in key restorative portions of neurosciences (CNS), cardiovascular (CVS), against retroviral, hostile to diabetics, Anti-biotics and gastroenterology. 

The organization began its activity with an extremely cost-proficient item fabricating capacity and has a lot of faithful clients, presently it has a wonderful situation in the high edge claim to fame conventional plans section. 

Aurobindo Pharma is one of the main pharma organizations which is fabricating dynamic drug fixings and definition items following the method involved with being information-driven. 

The organization is focused on R&D and owns an arrangement of multi-items with assembling units spread across different nations including India. It has a vast range of Pharma Products.



Cipla, as an association has been constructed one step at a time on the establishment of care. Really focusing On Life has consistently been and keeps on leftover, our directing reason. Driven by a similar reason, we have stretched out our essence to 80+ nations giving more than 1,500 items across different helpful classes in 50+ measurement structures. To make medical services more reasonable around the world, we are extending our essence in the critical business sectors of India, South Africa, the U.S. among different economies of the arising scene. 

For more than eighty years, having an effect on patients has motivated each part of Cipla’s work. Our worldview changing proposal of a triple enemy of retroviral treatment in HIV/AIDS at not exactly a dollar daily in Africa in 2001 is generally recognized as having added to bringing comprehensiveness, openness and moderateness to the focal point of the HIV development. A capable corporate resident, Cipla’s compassionate way to deal with medical care in a quest for its motivation of Caring for Life and profound established local area connects any place it is available, settle on it an accomplice of decision for worldwide wellbeing bodies and partners. 


Dr. Reddys Labs 

Researcher and business visionary Dr. K Anji Reddy set up Dr. Reddy’s Laboratories with the vision to make meds open to everybody. Starting with the assembling of dynamic fixings (APIs) for Ibuprofen and afterward Methyldopa, the counter hypertensive medication beforehand inaccessible in India, we later stretched into definitions. In 1988, we turned into the biggest exporter of Ibuprofen API in India with deals to the US, Spain, Italy, and Japan. We additionally started to send out dynamic elements for Norfloxacin and Ciprofloxacin to Europe and the Far East in 1990. This was a first for an Indian drug organization. 


Sun Pharma 

We produce and market a huge container of drug plans covering a wide range of constant and intense treatments. It incorporates generics, marked generics, claim to fame, intricate or hard to make innovation escalated items, over-the-counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and Intermediates. Our wide arrangement of in excess of 2000 top-notch particles covers various measurement structures, including tablets, containers, injectables, inhalers, salves, creams, and fluids. 

Consistently, we sell more than 30 billion dosages covering neuro-psychiatry, cardiology, gastroenterology, hostile to infectives, diabetology, oncology, ophthalmology, dermatology, urology, nephrology and respiratory among others. 



At Lupin, we are directed consistently by our guarantee of really focusing on our clients’ wellbeing and prosperity. To accomplish this evenhanded, we have put resources into research, consistent learning and innovation to foster top caliber and moderate drugs to address neglected patient requirements. 

As we proceed to develop and extend, we have stayed unflinching in our expressed target: to produce reasonable and quality meds. This is worked with by cutting-edge fabricating offices, industry-best climate, wellbeing and security rehearses, and a solid accentuation on quality. 

Lupin has extended and developed complexity since its initiation in 1968. Today, Lupin utilizes 20,000+ individuals in 11 nations across six landmasses, empowering protected and dependable conveyance of drugs to our patients across 100+ nations. 


Zydus Cadila 

Zydus Cadila, a main Indian Pharmaceutical organization is a completely coordinated, worldwide medical services supplier. With inside and out area aptitude in the field of medical services, it has solid abilities across the range of the drug esteem chain. From definitions to dynamic drug fixings and creature medical services items to wellbeing items, Zydus has procured a standing among Indian drug organizations for giving far-reaching and complete medical services arrangements. 

One of the notable components of Zydus is its rich history and genealogy. The beginning of the organization dates right back to the 1950s. The organization was established in the year 1952 by Mr. Ramanbhai B. Patel (late), an original business person and a doyen in the field of Indian Pharmaceuticals. 

In 1995, the gathering was rebuilt and accordingly was framed Cadila Healthcare under the aegis of the Zydus bunch. From an unassuming turnover Rs. 250 crores in 1995 the gathering saw a huge monetary development and enrolled a turnover of over Rs. 15,000 crores in FY-21. 

Sticking to its image guarantee of being committed to life in the entirety of its measurements, Zydus keeps on enhancing with an unswerving concentration to address the neglected medical care needs. All the while it rededicates itself to its central goal of making better, more joyful networks across the globe. 



Glenmark was established with a dream to arise as a main coordinated exploration-based, worldwide drug organization. Our marked generics business has a critical presence in business sectors across arising economies including India. 

The generics business benefits the prerequisites of created markets like US and Western Europe. Our API business sells items in more than 65 nations including the US, different nations in the EU, South America and India. 

With 14 assembling offices and 3 R&D focuses devoted to the objective of advancing lives across the globe we accept that the genuine power behind our proceeded with victories are devoted workers from across 60 identities, focused on making ‘another way for another world’. 


Alkem Lab 

We are an excellent centered association. Alkem’s vision and culture of excellent fixation reflects in its activities. Our assembling tasks are centered around delivering generics, marked generics, over-the-counter (OTC) items, Active Pharmaceutical Ingredients (APIs) and nutraceuticals. These are accessible in the full scope of dose structures, which incorporate, cases, injectable and fluids. This aides in outfitting quality details in India just as 50 different nations. 

We have cutting edge offices that utilize state of the art fabricating procedures for delivering top tier items. Alkem has a broad assembling impression which has a sum of 21 assembling offices, out of which 19 are in India and 2 are in the United States. 

We have different assembling offices at Daman, Baddi, Indore and Sikkim. These have administrative endorsements from offices like USFDA, MHRA – UK, SAHPRA-South Africa, TGA – Australia, ANVISA – Brazil, WHO – Geneva, TPD – Health Canada, PPB – Kenya, NDA – Uganda, MOH – Sudan, INVIMA – Colombia, TFDA – Tanzania, Zimbabwe, BfArM-Germany and Other Africa, Asian and CIS Countries. They are regularly examined to guarantee consistence with Current Good Manufacturing Practices (cGMP). 

Our Production Team has more than 3,000 fit people, who work pair with the Quality Team to convey top-quality items. Our administration outfits sufficient assets to guarantee quality redemption. All assembling units are furnished with Quality Control Units that guarantee quality at each stage. 


Divis Labs 

Divi’s has been set up for over 30 years in Hyderabad, India with two assembling units and is among the top drugs organizations in India. Divi’s is perceived as a ‘Solid Supplier of nonexclusive APIs (Active drugs fixings)’ and a dependable ‘Custom Manufacturer’ to Big Pharma and furthermore is among the top API makes on the planet. Divi’s is the main producer of APIs(Active drugs fixings), Intermediates and Registered beginning materials offering top-notch items with the most elevated level of consistence and uprightness to more than 95 nations. Divi’s as of late arrived at the achievement of being one among the main 3 API producers on the planet and one among the top API organizations in Hyderabad  ~17,000 exceptionally prepared experts across offices and ~500 researchers at Divi’s work together to carry elite items to clients. Divi’s is a Public restricted organization recorded on the Indian stock trade with an income of INR ~7050 crores (~$960M) for the year 2020-21. Progressed producing offices both in Hyderabad and Vizag have been investigated on different occasions by USFDA, EU GMP (UK, Slovenia, German, Irish specialists), HEALTH CANADA, TGA, ANVISA , COFEPRIS, PMDA and MFDS wellbeing specialists.